NARCOLEPSY
Clinical trials for NARCOLEPSY explained in plain language.
Never miss a new study
Get alerted when new NARCOLEPSY trials appear
Sign up with your email to follow new studies for NARCOLEPSY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Switching narcolepsy drugs may lower blood pressure
Disease control CompletedThis study looked at 155 adults with narcolepsy who switched from a high-sodium medication (sodium oxybate) to a low-sodium version (Xywav). The goal was to see if their blood pressure changed. The results could help doctors and patients choose the best treatment for managing nar…
Matched conditions: NARCOLEPSY
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
New narcolepsy drug LUMRYZ studied in Real-World setting
Symptom relief CompletedThis study looked at how LUMRYZ, a medicine for narcolepsy, works when used in regular medical practice. 71 adults with narcolepsy filled out questionnaires about their symptoms, treatment experience, and quality of life over 4 months. The main goal was to see if daytime sleepine…
Matched conditions: NARCOLEPSY
Sponsor: Avadel • Aim: Symptom relief
Last updated May 26, 2026 07:24 UTC
-
New Once-Nightly pill may simplify narcolepsy treatment
Symptom relief CompletedThis study tested a new once-nightly medication (FT218) for people with narcolepsy who experience excessive daytime sleepiness and sudden muscle weakness (cataplexy). The goal was to see if it is safe and tolerable over the long term, and whether people currently taking a twice-n…
Matched conditions: NARCOLEPSY
Phase: PHASE3 • Sponsor: Avadel • Aim: Symptom relief
Last updated May 26, 2026 07:22 UTC
-
New drug shows promise for narcolepsy symptom control
Symptom relief CompletedThis study tested the long-term safety and effectiveness of AXS-12 in 68 people with narcolepsy who experience sudden muscle weakness (cataplexy) and severe daytime sleepiness. Participants had already completed an earlier study of the same drug. The goal was to see if AXS-12 can…
Matched conditions: NARCOLEPSY
Phase: PHASE3 • Sponsor: Axsome Therapeutics, Inc. • Aim: Symptom relief
Last updated May 26, 2026 07:21 UTC
-
New narcolepsy pill tested for quick start tolerability
Symptom relief CompletedThis study tested a new delayed-release form of the drug pitolisant (called HBS-201) in 46 adults with narcolepsy. The main goal was to see if starting at a full therapeutic dose is tolerable, meaning few people stop treatment due to side effects. Researchers tracked how many par…
Matched conditions: NARCOLEPSY
Phase: PHASE1 • Sponsor: Harmony Biosciences Management, Inc. • Aim: Symptom relief
Last updated May 22, 2026 14:01 UTC
-
Can a wakefulness drug make sleepy drivers safer? new study investigates.
Knowledge-focused CompletedThis study looked at how well people with narcolepsy or hypersomnia can drive while taking modafinil, a medication that promotes wakefulness. Twenty-seven licensed drivers who drove over 5,000 km per year took part. Researchers measured sleepiness and driving performance using a …
Matched conditions: NARCOLEPSY
Phase: NA • Sponsor: University Hospital, Bordeaux • Aim: Knowledge-focused
Last updated May 26, 2026 07:53 UTC
-
Narcoleptic Kids' weight gain mystery: metabolism under the microscope
Knowledge-focused CompletedThis study looked at 24 children (ages 6-17) with narcolepsy or hypersomnia to see if changes in their daily metabolism explain why they often gain weight and become obese. Researchers measured energy use at home and in the hospital using activity trackers. The goal was to uncove…
Matched conditions: NARCOLEPSY
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated May 26, 2026 07:52 UTC